499995-84-5 Usage
Uses
Used in Pharmaceutical Industry:
(S)-BOC-3 4-DIMETHOXY-BETA-PHE-OH is used as a protected amino acid in peptide synthesis for the development of new pharmaceutical compounds. The BOC protection allows for the synthesis of complex peptide structures without premature reactivity, ensuring the stability and integrity of the final product.
Used in Scientific Research:
(S)-BOC-3 4-DIMETHOXY-BETA-PHE-OH is used as a research compound in the study of amino acid chemistry and peptide synthesis. Its unique structural attributes make it a valuable tool for understanding the interactions and reactions of amino acids in various biological and chemical contexts.
Used in Drug Delivery Systems:
(S)-BOC-3 4-DIMETHOXY-BETA-PHE-OH is used as a component in the design of drug delivery systems, particularly for compounds that require enhanced lipophilicity to improve their ability to cross biological membranes. Its structural features can be exploited to create more effective and targeted drug delivery platforms.
Used in Organic Synthesis:
(S)-BOC-3 4-DIMETHOXY-BETA-PHE-OH is used as a starting material or intermediate in the synthesis of complex organic molecules. The presence of the hydroxyl (OH) group makes it a versatile building block for further chemical reactions, leading to the development of novel compounds with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 499995-84-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,9,9,9 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 499995-84:
(8*4)+(7*9)+(6*9)+(5*9)+(4*9)+(3*5)+(2*8)+(1*4)=265
265 % 10 = 5
So 499995-84-5 is a valid CAS Registry Number.
499995-84-5Relevant articles and documents
New entry to the asymmetric synthesis of (-)-lasubine I and (+)-subcosine I
Yamazaki, Naoki,Atobe, Masakazu,Kibayashi, Chihiro,Aoyagi, Sakae
scheme or table, p. 433 - 439 (2009/12/05)
A new synthetic entry to (-)-lasubine I and (+)-subcosine I has been established by employing the (S)-allylalkoxy benzylamine as a chiral synthon. The synthesis involves the formation of an α,β-unsaturated lactone by RCM reaction followed by an intramolec